Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Gerona

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2023
Screening of Environmental Chemicals to Characterize Exposures in Participants With Systemic Lupus ErythematosusCristina M Lanata, Kimberly E Taylor, James Hurst-Hopf, et al.
International Journal of Hygiene and Environmental Health|June 30, 2020
Sources of exposure to urinary phthalates among couples undergoing infertility treatmentThoin F Begum, Roy Gerona, Jonathan Melamed, et al.
Plos One|December 8, 2017
Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosisVidya Mave, Aarti Kinikar, Anju Kagal, et al.
Brain and Behavior|November 18, 2024
Acceptability and Feasibility of Using Hair Samples for Chronic Stress Measurement Among Transgender Women in BrazilSophia Zamudio-Haas, Paula Galdino Cardin de Carvalho, Alexander Marr, et al.
MMWR. Morbidity and Mortality Weekly Report|October 9, 2015
Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015Amelia M Kasper, Alison D Ridpath, Justin K Arnold, et al.
ACS Chemical Neuroscience|October 22, 2021
NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?Adam Ametovski, Elizabeth A Cairns, Katharina Elisabeth Grafinger, et al.
Lancet (London, England)|October 15, 2017
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialAri J Green, Jeffrey M Gelfand, Bruce A Cree, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 12, 2015
An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACAJoseph A Tyndall, Roy Gerona, Giuliano De Portu, et al.
MMWR. Morbidity and Mortality Weekly Report|May 1, 2025
Overdoses Involving Medetomidine Mixed with Opioids - Chicago, Illinois, May 2024Amy Nham, John N Le, Shawn A Thomas, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2023
Screening of Environmental Chemicals to Characterize Exposures in Participants With Systemic Lupus ErythematosusCristina M Lanata, Kimberly E Taylor, James Hurst-Hopf, et al.
International Journal of Hygiene and Environmental Health|June 30, 2020
Sources of exposure to urinary phthalates among couples undergoing infertility treatmentThoin F Begum, Roy Gerona, Jonathan Melamed, et al.
Plos One|December 8, 2017
Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosisVidya Mave, Aarti Kinikar, Anju Kagal, et al.
Brain and Behavior|November 18, 2024
Acceptability and Feasibility of Using Hair Samples for Chronic Stress Measurement Among Transgender Women in BrazilSophia Zamudio-Haas, Paula Galdino Cardin de Carvalho, Alexander Marr, et al.
MMWR. Morbidity and Mortality Weekly Report|October 9, 2015
Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015Amelia M Kasper, Alison D Ridpath, Justin K Arnold, et al.
ACS Chemical Neuroscience|October 22, 2021
NNL-3: A Synthetic Intermediate or a New Class of Hydroxybenzotriazole Esters with Cannabinoid Receptor Activity?Adam Ametovski, Elizabeth A Cairns, Katharina Elisabeth Grafinger, et al.
Lancet (London, England)|October 15, 2017
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialAri J Green, Jeffrey M Gelfand, Bruce A Cree, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 12, 2015
An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACAJoseph A Tyndall, Roy Gerona, Giuliano De Portu, et al.
MMWR. Morbidity and Mortality Weekly Report|May 1, 2025
Overdoses Involving Medetomidine Mixed with Opioids - Chicago, Illinois, May 2024Amy Nham, John N Le, Shawn A Thomas, et al.
Pageof 6